These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12403401)

  • 41. [Balkan endemic nephropathy in Bosnia and Herzegovina--renal registry report].
    Mesić E; Lukić L; Dolenec L; Petković N; Stipancić Z; Resić H; Trnacević S; Halilbasić A
    Med Arh; 2006; 60(4):240-2. PubMed ID: 16761518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidemiology of hemodialysis patients in Aleppo city.
    Moukeh G; Yacoub R; Fahdi F; Rastam S; Albitar S
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):140-6. PubMed ID: 19112237
    [TBL] [Abstract][Full Text] [Related]  

  • 43. UK Renal Registry 12th Annual Report (December 2009): chapter 4: UK ESRD prevalent rates in 2008: national and centre-specific analyses.
    Byrne C; Steenkamp R; Castledine C; Ansell D; Feehally J
    Nephron Clin Pract; 2010; 115 Suppl 1():c41-67. PubMed ID: 20413956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal replacement therapy in the Canary Islands: demographic and survival analysis.
    Lorenzo V; Sanchez E; Vega N; Hernandez D
    J Nephrol; 2006; 19(1):97-103. PubMed ID: 16523433
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
    Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparing Dialysis Modality and Cardiovascular Mortality in Patients on Hemodialysis and Peritoneal Dialysis.
    Refaat H; Sany D; Mohab A; Ezzat H
    Adv Perit Dial; 2016; 32():22-31. PubMed ID: 28988586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses.
    Steenkamp R; Castledine C; Feest T; Fogarty D
    Nephron Clin Pract; 2011; 119 Suppl 2():c27-52. PubMed ID: 21894040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. End-stage renal disease in India and Pakistan: incidence, causes, and management.
    Sakhuja V; Kohli HS
    Ethn Dis; 2006; 16(2 Suppl 2):S2-20-3. PubMed ID: 16774005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Causes of chronic renal failure and clinical status of patients during initiation of hemodialysis therapy in upper Silesian region].
    Zarzecki M; Chudek J; Kułach A; Hołowiecka A; Kania M; Kopeć P; Kukla M; Machała L; Pyda M; Rozmus W; Szpak S; Wiecek A
    Wiad Lek; 2004; 57(3-4):145-50. PubMed ID: 15307522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
    Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
    Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
    [TBL] [Abstract][Full Text] [Related]  

  • 51. End-stage renal disease in sub-Saharan and South Africa.
    Naicker S
    Kidney Int Suppl; 2003 Feb; (83):S119-22. PubMed ID: 12864889
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Renal Epidemiology and Information Network: 2006 annual report].
    Couchoud C; Lassalle M; Stengel B; Jacquelinet C
    Nephrol Ther; 2008 Jul; 4 Suppl 2():S53-167. PubMed ID: 19058350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status of dialytic therapy in Korea.
    Kim SY; Jin DC; Bang BK
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S2-9. PubMed ID: 15012684
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Renal Epidemiology and Information Network: 2007 annual report ].
    Couchoud C; Lassalle M; Stengel B; Jacquelinet C
    Nephrol Ther; 2009 Jun; 5 Suppl 1():S3-144. PubMed ID: 19524212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Latin American Dialysis and Renal Transplantation Registry Annual Report 2002.
    Cusumano AM; Di Gioia C; Hermida O; Lavorato C;
    Kidney Int Suppl; 2005 Aug; (97):S46-52. PubMed ID: 16014100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ESRD in Australia and New Zealand at the end of the millennium: a report from the ANZDATA registry.
    McDonald SP; Russ GR; Kerr PG; Collins JF;
    Am J Kidney Dis; 2002 Dec; 40(6):1122-31. PubMed ID: 12460029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal replacement therapy in Ukraine: epidemiology and international comparisons.
    Kolesnyk I; Noordzij M; Kolesnyk M; Kulyzky M; Jager KJ
    Clin Kidney J; 2014 Jun; 7(3):330-5. PubMed ID: 25852905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Burden of end-stage renal disease (ESRD) in Latin America.
    Rosa-Diez G; Gonzalez-Bedat M; Ferreiro A; García-García G; Fernandez-Cean J; Douthat W
    Clin Nephrol; 2016 Supplement 1; 86 (2016)(13):29-33. PubMed ID: 27509582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overview: end-stage renal disease in the developing world.
    Barsoum RS
    Artif Organs; 2002 Sep; 26(9):737-46. PubMed ID: 12197924
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of upper urinary tract tumors in the region of Balkan nephropathy with those of other regions of Yugoslavia].
    Djokic M; Hadzi-Djokic J; Nikolic J; Dragicevic D; Radivojevic D
    Prog Urol; 1999 Feb; 9(1):61-8. PubMed ID: 10212954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.